Ostreotide (somatostatin analogue) treatment reduces endothelial cell dysfunction in patients with diabetes mellitus

Autoren

Clemens A, Klevesath MS, Hofmann M, Raulf F, Henkels M, Amiral J, Seibel MJ, Zimmermann J, Ziegler R, Wahl P, Nawroth PP

Abstract